Oncology

News

Novartis oncology CEO quits after less than a year

Novartis has appointed Susanne Schaffert to lead its oncology division after incumbent CEO Liz Barrett decided to leave for another job.

News

AbbVie suffers fresh setback with lung cancer drug Rova-T

AbbVie has suffered a further setback with its oncology drug Rova-T, after early data from a lung cancer trial suggested that patients were living longer when treated with standard therapy.

News

Astellas scores first US blood cancer approval with Xospata

The FDA has approved Astellas’ Xospata for certain patients with acute myeloid leukaemia – the company’s first drug approved in blood cancer.

Views & Analysis

Merck & Co’s cancer blockbuster Keytruda funds cutting edge ...

Merck & Co is enjoying blockbuster revenues as its cancer immunotherapy Keytruda is becoming standard of care in a range of cancers.

News

Blockchain firm Witty Health launches digital cancer decisio...

The health blockchain technology firm Witty Health has launched OncoPower, a digital tool helping oncologists with their decision making.

News

AstraZeneca on course to long term growth, says CEO

AstraZeneca’s CEO Pascal Soriot has said the company has returned to long-term growth following a difficult period where patents on key products expired.

Novartis oncology CEO quits after less than a year

AbbVie suffers fresh setback with lung cancer drug Rova-T

Astellas scores first US blood cancer approval with Xospata

Merck & Co’s cancer blockbuster Keytruda funds cutting edge ...

Blockchain firm Witty Health launches digital cancer decisio...

AstraZeneca on course to long term growth, says CEO

Novo turns to Hengrui for another oral obesity drug

Discover a new era of healthcare panel engagement: Grounded ...

Oncology

Editor's Picks